Skip to content


Featured article: A case report of recurrent C3 glomerulonephritis 18 months after renal transplantation

1The recurrence of glomerulonephritis (GN) is critical to the prognosis of long-term renal transplant graft survival. C3 GN is a rare GN with a poor prognosis, and there are only a few reports of recurrent cases after renal transplantation. The authors recently experienced a case highly suspected of C3 GN recurrence.

See this article.

Featured article: Rehabilitation nutrition support for a hemodialysis patient with protein-energy wasting and sarcopenic dysphagia: a case report

2Patients with end-stage renal failure may exhibit sarcopenia and protein-energy wasting (PEW). The authors report a case of improvement in physical function, muscle mass, and muscle strength by management of rehabilitation nutrition in a maintenance hemodialysis patient with PEW and sarcopenia.

See this article.

Featured article: Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review

3TAFRO (thrombocytopenia, anasarca, fever, reticulin myelofibrosis/renal failure, and organomegaly) syndrome is a systemic inflammatory disorder and unique clinicopathological variant of idiopathic multicentric Castleman disease that was proposed in Japan. Prompt diagnosis is critical because TAFRO syndrome is a progressive and life threating disease. Some cases are refractory to immunosuppressive treatments. Renal impairment is frequently observed in patients with TAFRO syndrome, and some severe cases require hemodialysis. Histological evaluation is important to understand the pathophysiology of TAFRO syndrome. However, systemic histopathological evaluation through autopsy in TAFRO syndrome has been rarely reported previously.

See this article.


  1. Content type: Position Statement


    Authors: Kent Doi, Osamu Nishida, Takashi Shigematsu, Tomohito Sadahiro, Noritomo Itami, Kunitoshi Iseki, Yukio Yuzawa, Hirokazu Okada, Daisuke Koya, Hideyasu Kiyomoto, Yugo Shibagaki, Kenichi Matsuda, Akihiko Kato, Terumasa Hayashi, Tomonari Ogawa, Tatsuo Tsukamoto…

Most accessed articles RSS

View all articles

Upcoming conferences

The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama

The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
12−14 June 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka

The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
June 2021, Pacifico Yokohama

The 52nd Annual Meeting of the Japanese Society for Clinical Renal Transplantation 
13-15 February 2019, Knowledge Capital Congress Convention Center

The 24th Annual Meeting of the Japanese Society for Peritoneal Dialysis
6 - 7 October 2018, JR Hotel Clement Tokushima

The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD)
5-7 September 2019, Nagoya Congress Center

The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
30 November - 1 December 2019, Hiroshima International Conference Center

The 29th Annual Meeting of the Japan Society for Blood Purification Critical Care
19 - 20 October 2018, WINC Aichi

The 30th Annual Meeting of the Japan Society for Blood Purification Critical Care
26-27 October 2019, Hamamatsu ACT

The 9th Annual Meeting of the Japanese Society of Renal Rehabilitation
9-10 March 2019, B-ConPlaza (Beppu Convention Center)

Submit your manuscript

RRT logo

Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Society affiliations

Renal Replacement Therapy is the official publication of the following societies:

Japanese Society for Dialysis Therapy (JSDT)

Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.

Japanese Society for Clinical Renal Transplantation (JSCRT)

The Japanese Society for Clinical Renal Transplantation (JSCRT) was founded in 1969 on the vision of promoting the advancement of the science and practice of renal transplantation. JSCRT has expanded to include nearly 1,500 renal transplant professionals, including surgeons, physicians, pediatrician, nurses, coordinators, social workers, pharmacists, and dieticians. JSCRT is also dedicated to educating renal transplant professionals, to promoting research, and to advocating the highest quality care for patients.

Japanese Society for Peritoneal Dialysis (JSPD)

The Japanese Society for Peritoneal Dialysis (JSPD) aims to contribute to the advancement of medicine and medical practice, the development of academic culture and people’s welfare through implementing programs for advancement, development and propagation of medical practice and research regarding renal failure and peritoneal dialysis therapies for people all over Japan. JSPD was established in 1995, and has currently 1,500 members.

Japan Society for Blood Purification in Critical Care (JSBPCC)

The Japan Society for Blood Purification in Critical Care was founded in 1990 and aims to further the development and establishment of acute blood purification, such as continuous renal replacement therapy (CRRT). JSBPCC comprises nephrologists, emergency/critical care physicians, as well as clinical engineers and nurses mainly working in intensive care units (ICU). JSBPCC is dedicated to the development of safe and effective blood purification therapy for saving the lives of critically ill patients.

Japanese Society of Renal Rehabilitation (JSRR)

The Japanese Society of Renal Rehabilitation (JERR) promotes the progress and disseminate of the knowledge of renal rehabilitation through the presentation of papers on theoretical studies of nephrology, comprehensive rehabilitation and its practical applications, exchange of knowledge, encouragement of continuing education for members, enhancement of mutual coordination and cooperation of members and also related domestic and foreign societies. JSRR was established in 2011, and has currently 640 members and 75 facilities.

About the Editor

Prof Takashi Shigematsu, Editor-in-Chief

Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.


2017 Journal Metrics

  • Speed
    34 days from submission to first decision
    134 days from submission to acceptance
    21 days from acceptance to publication